DR. RUTH MARGRIT RUPRECHT, M.D., PH.D.
Medical Practice in Boston, MA
License number
Massachusetts 53666
Category
Medical Practice
Type
Specialist
Address
Address
44 Binney St Dana-Farber Cancer Institute, Boston, MA 02115
Phone
(617) 632-3719
(617) 632-3112 (Fax)
(617) 632-3112 (Fax)
Personal information
See more information about RUTH MARGRIT RUPRECHT at radaris.comName
Address
Phone
127 Winthrop Rd, Brookline, MA 02445
Professional information
Dr. Ruth M Ruprecht, Boston MA - MD (Doctor of Medicine)
Specialties:
Oncology, Medical Oncology
Address:
44 Binney St, Boston 02115
(617) 632-3719 (Phone), (617) 632-3112 (Fax)
(617) 632-3719 (Phone), (617) 632-3112 (Fax)
Certifications:
Internal Medicine, 1980, Medical Oncology, 1987
Awards:
Healthgrades Honor Roll
Languages:
English
Hospitals:
44 Binney St, Boston 02115
Dana - Farber Cancer Institute
450 Brookline Ave, Boston 02115
Dana - Farber Cancer Institute
450 Brookline Ave, Boston 02115
Education:
Medical School
University of Miami / School of Medicine
Graduated: 1977
University Of California-Los Angeles
Meml Sloan-Kettering Ctr
University of Miami / School of Medicine
Graduated: 1977
University Of California-Los Angeles
Meml Sloan-Kettering Ctr
Professor Of Medicine At Dfci
Location:
Greater Boston Area
Industry:
Research
Experience:
DFCI (Research industry): Professor of Medicine, (-)
Ruth Margrit Ruprecht, Boston MA
Specialties:
Internal Medicine, Medical Oncology
Work:
Dana-Farber Cancer Institute
44 Binney St, Boston, MA 02115
44 Binney St, Boston, MA 02115
Education:
University of Miami(1977)
Modified Human Immunodeficiency Virus Clade C Envelope Polypeptides Obtained From A Zambian Isolate
US Patent:
8603490, Dec 10, 2013
Filed:
Sep 29, 2008
Appl. No.:
12/286159
Inventors:
Ruth M. Ruprecht - Boston MA, US
Assignee:
Dana-Farber Cancer Institute, Inc. - Boston MA
International Classification:
A61K 39/21, C07H 21/04
US Classification:
4242081, 4241991, 536 2372
Abstract:
The invention provides methods and compositions for raising an immune response in a subject by administering an HIV antigen. The HIV antigens include HIV clade C polynucleotides and polypeptides. The invention also provides for recombinant HIV viral particles and compositions.
Dideoxynucleoside-5'-Phosphonoformic Acid Compounds
US Patent:
5132414, Jul 21, 1992
Filed:
May 10, 1990
Appl. No.:
7/521748
Inventors:
Andre Rosowsky - Needham MA
Ruth M. Ruprecht - Boston MA
Ruth M. Ruprecht - Boston MA
Assignee:
Dana-Farber Cancer Institute, Inc. - Boston MA
International Classification:
C07H 1900
US Classification:
536 27
Abstract:
Compounds having the structure ##STR1## in which R is alkyl, aryl, or aralkyl, A is hydrogen or a water-soluble cation, B is hydrogen, fluorine, or azido, the bond is saturated when B is fluorine or azido and is saturated or unsaturated when B is hydrogen, and D is a purine or pyrimidine base are effective inhibitors of retrovirus replication.